Dystrophic xanthomatosis in mycosis fungoides
- 1 January 1978
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 114 (1) , 102-103
- https://doi.org/10.1001/archderm.114.1.102
Abstract
The condition of a patient with advanced mycosis fungoides was treated with cyclic combination chemotherapy [mechlorethamine hydrochloride, vincristine sulfate, blomycin sulfate, prednisone and procarbazine hydrochloride]. At the sites of regressing tumors, yellow nodules appeared that were clinically and histogically benign xanthomata. The probable multifactorial pathogenesis of dystrophic xanthomata is discussed and previous case reports are reviewed.This publication has 6 references indexed in Scilit:
- The Ultrastructure of an Abnormal Cell in Sézary’s SyndromeBlood, 1968
- Low-density lipoprotein accumulation in actively growing xanthomasJournal of Atherosclerosis Research, 1967
- Generalized plane xanthoma and systemic diseaseArchives of Dermatology, 1966
- The incorporation of 14C-labelled particulate cholesterol into lipoprotein by macrophagesJournal of Atherosclerosis Research, 1964
- The Lipids in Xanthomata *Journal of Clinical Investigation, 1964
- Studies on the Origin of the Lipid Components of XanthomataCirculation Research, 1963